Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
Identifieur interne : 005692 ( Main/Exploration ); précédent : 005691; suivant : 005693Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
Auteurs : Burton L. Scott [États-Unis] ; Jankovic [États-Unis] ; Donald T. Donovan [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 1996-07.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Enfant.
English descriptors
- KwdEn :
- Adolescent, Attention deficit hyperacitivity disorder, Botulinum Toxins (administration & dosage), Botulinum toxin, Botulism, Case study, Chemotherapy, Child, Coprolalia, Humans, Injections, Intramuscular, Language disorder, Male, Obsessive compulsive disorder, Tic, Tics, Tourette Syndrome (drug therapy), Tourette Syndrome (genetics), Tourette's syndrome, Toxin, Treatment, Treatment Outcome, Treatment efficiency, Verbal Behavior (drug effects), Vocal Cords (drug effects), Vocal cord.
- MESH :
- chemical , administration & dosage : Botulinum Toxins.
- drug effects : Verbal Behavior, Vocal Cords.
- drug therapy : Tourette Syndrome.
- genetics : Tourette Syndrome.
- Adolescent, Humans, Injections, Intramuscular, Male, Treatment Outcome.
Abstract
We describe a 13‐year‐old boy with Tourette's syndrome (TS) manifested chiefly by severe coprolalia, obsessive compulsive disorder, and attention deficit hyperactivity disorder. He was treated with unilateral injections of botulinum toxin to the vocal cord and experienced marked improvement in coprolalia as well as marked reduction in the premonitory urges associated with the vocal tics and coprolalia. As a result of the improvement, the patient was able to attend school and church and was able to socialize. Botulinum toxin may interfere with a sensory reflex are required to perpetuate tics and coprolalia in TS, possibly by reducing local build‐up of tension or muscle contraction in affected areas.
Url:
DOI: 10.1002/mds.870110413
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003463
- to stream Istex, to step Curation: 003463
- to stream Istex, to step Checkpoint: 003B94
- to stream PubMed, to step Corpus: 004807
- to stream PubMed, to step Curation: 004807
- to stream PubMed, to step Checkpoint: 004866
- to stream Ncbi, to step Merge: 004B75
- to stream Ncbi, to step Curation: 004B75
- to stream Ncbi, to step Checkpoint: 004B75
- to stream Main, to step Merge: 008798
- to stream PascalFrancis, to step Corpus: 003367
- to stream PascalFrancis, to step Curation: 003457
- to stream PascalFrancis, to step Checkpoint: 003402
- to stream Main, to step Merge: 008934
- to stream Main, to step Curation: 005692
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome</title><author><name sortKey="Scott, Burton L" sort="Scott, Burton L" uniqKey="Scott B" first="Burton L." last="Scott">Burton L. Scott</name></author><author><name sortKey="Jankovic" sort="Jankovic" uniqKey="Jankovic" last="Jankovic">Jankovic</name></author><author><name sortKey="Donovan, Donald T" sort="Donovan, Donald T" uniqKey="Donovan D" first="Donald T." last="Donovan">Donald T. Donovan</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1002/mds.870110413</idno><idno type="url">https://api.istex.fr/document/6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003463</idno><idno type="wicri:Area/Istex/Curation">003463</idno><idno type="wicri:Area/Istex/Checkpoint">003B94</idno><idno type="wicri:doubleKey">0885-3185:1996:Scott B:botulinum:toxin:injection</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:8813224</idno><idno type="wicri:Area/PubMed/Corpus">004807</idno><idno type="wicri:Area/PubMed/Curation">004807</idno><idno type="wicri:Area/PubMed/Checkpoint">004866</idno><idno type="wicri:Area/Ncbi/Merge">004B75</idno><idno type="wicri:Area/Ncbi/Curation">004B75</idno><idno type="wicri:Area/Ncbi/Checkpoint">004B75</idno><idno type="wicri:doubleKey">0885-3185:1996:Scott B:botulinum:toxin:injection</idno><idno type="wicri:Area/Main/Merge">008798</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:96-0334539</idno><idno type="wicri:Area/PascalFrancis/Corpus">003367</idno><idno type="wicri:Area/PascalFrancis/Curation">003457</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">003402</idno><idno type="wicri:doubleKey">0885-3185:1996:Scott B:botulinum:toxin:injection</idno><idno type="wicri:Area/Main/Merge">008934</idno><idno type="wicri:Area/Main/Curation">005692</idno><idno type="wicri:Area/Main/Exploration">005692</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome</title><author><name sortKey="Scott, Burton L" sort="Scott, Burton L" uniqKey="Scott B" first="Burton L." last="Scott">Burton L. Scott</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Jankovic" sort="Jankovic" uniqKey="Jankovic" last="Jankovic">Jankovic</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Donovan, Donald T" sort="Donovan, Donald T" uniqKey="Donovan D" first="Donald T." last="Donovan">Donald T. Donovan</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Otorhinolaryngology, Baylor College of Medicine, Houston, Texas</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1996-07">1996-07</date><biblScope unit="vol">11</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="431">431</biblScope><biblScope unit="page" to="433">433</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1</idno><idno type="DOI">10.1002/mds.870110413</idno><idno type="ArticleID">MDS870110413</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Attention deficit hyperacitivity disorder</term><term>Botulinum Toxins (administration & dosage)</term><term>Botulinum toxin</term><term>Botulism</term><term>Case study</term><term>Chemotherapy</term><term>Child</term><term>Coprolalia</term><term>Humans</term><term>Injections, Intramuscular</term><term>Language disorder</term><term>Male</term><term>Obsessive compulsive disorder</term><term>Tic</term><term>Tics</term><term>Tourette Syndrome (drug therapy)</term><term>Tourette Syndrome (genetics)</term><term>Tourette's syndrome</term><term>Toxin</term><term>Treatment</term><term>Treatment Outcome</term><term>Treatment efficiency</term><term>Verbal Behavior (drug effects)</term><term>Vocal Cords (drug effects)</term><term>Vocal cord</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Botulinum Toxins</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Verbal Behavior</term><term>Vocal Cords</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Tourette Syndrome</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Tourette Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Humans</term><term>Injections, Intramuscular</term><term>Male</term><term>Treatment Outcome</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Botulisme</term><term>Chimiothérapie</term><term>Coprolalie</term><term>Corde vocale</term><term>Efficacité traitement</term><term>Enfant</term><term>Etude cas</term><term>Tic</term><term>Toxine</term><term>Traitement</term><term>Trouble langage</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Enfant</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We describe a 13‐year‐old boy with Tourette's syndrome (TS) manifested chiefly by severe coprolalia, obsessive compulsive disorder, and attention deficit hyperactivity disorder. He was treated with unilateral injections of botulinum toxin to the vocal cord and experienced marked improvement in coprolalia as well as marked reduction in the premonitory urges associated with the vocal tics and coprolalia. As a result of the improvement, the patient was able to attend school and church and was able to socialize. Botulinum toxin may interfere with a sensory reflex are required to perpetuate tics and coprolalia in TS, possibly by reducing local build‐up of tension or muscle contraction in affected areas.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region></list><tree><country name="États-Unis"><region name="Texas"><name sortKey="Scott, Burton L" sort="Scott, Burton L" uniqKey="Scott B" first="Burton L." last="Scott">Burton L. Scott</name></region><name sortKey="Donovan, Donald T" sort="Donovan, Donald T" uniqKey="Donovan D" first="Donald T." last="Donovan">Donald T. Donovan</name><name sortKey="Jankovic" sort="Jankovic" uniqKey="Jankovic" last="Jankovic">Jankovic</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005692 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005692 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6C664A0C434AF7C2E6C7348FAEDCC9982D352CC1
|texte= Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
}}
| This area was generated with Dilib version V0.6.23. |  |